The steadily increasing prevalence and high costs of treating chronic joint pain worldwide poses a challenge for healthcare systems and healthcare payers. New research published today in JAMA Network Open shows the effectiveness of a digital healthcare treatment with the potential to save insurance companies and their patients the costs and risks of joint surgeries – a finding that is especially promising as more patients turn to telemedicine as a safe treatment option amid the COVID-19 pandemic.
A new randomized controlled trial (RCT) conducted by the University of Nottingham using Joint Academy’s clinical evidence-based digital treatment for chronic joint pain is the first to find clinically important improvements of treating knee osteoarthritis digitally compared to traditional treatment. Patients receiving digital treatment reduced their pain by 41 percent, while patients receiving traditional
Tech Update
Study finds digital treatment for osteoarthritis is superior to traditional routine care
Meet Smash Ventures, the low-flying outfit that has quietly funded Epic Games among others
Oppo Find X3 Pro and Find X3 series: Everything we know so far (Feb. 24)
Distinguishing between two very similar pediatric brain conditions
For years, I’ve tried to work my way back into the middle class
Kleeen raises $3.8M to make front-end design for business applications easy
Android’s spring feature rollout includes a Google Maps dark mode